Last quarter (Q3 2024), Love Pharma Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Love Pharma Inc's net income was $-69.31K. See Love Pharma Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Sep 20	Sep 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 445.20K	$ 415.74K	$ 1.66M	$ 8.24M	$ 128.30K	$ 329.88K
Operating Income	$ -445.20K	$ -415.74K	$ -1.66M	$ -8.24M	$ -128.30K	$ -329.88K
Net Non Operating Interest Income Expense	$ ―	$ -17.22K	$ -19.14K	$ 10.28K	$ ―	$ ―
Other Income Expense	$ 92.34K	$ 80.51K	$ -2.00K	$ -1.27M	$ ―	$ ―
Pretax Income	$ -787.34K	$ -765.74K	$ -3.58M	$ -9.52M	$ -128.30K	$ -329.88K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -787.34K	$ -765.74K	$ -3.58M	$ -9.52M	$ -128.30K	$ -329.88K
Basic EPS	$ ―	$ -0.01	$ -0.09	$ -0.04	$ ―	$ ―
Diluted EPS	$ ―	$ -0.01	$ -0.09	$ -0.04	$ ―	$ ―
Basic Average Shares	$ 429.73M	$ 65.17M	$ 41.33M	$ 214.52M	$ 9.06M	$ 13.68M
Diluted Average Shares	$ 429.73M	$ 65.17M	$ 41.33M	$ 214.52M	$ 9.06M	$ 13.68M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 445.20K	$ 415.74K	$ 1.66M	$ -8.24M	$ -128.30K	$ -329.88K
Net Income From Continuing And Discontinued Operation	$ -787.34K	$ -765.74K	$ -3.58M	$ -9.52M	$ -128.30K	$ -329.88K
Normalized Income	$ -344.12K	$ -203.42K	$ -701.67K	$ -5.76M	$ -94.30K	$ -242.46K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -787.34K	$ -748.52K	$ -3.56M	$ -9.51M	$ -128.30K	$ -329.88K
EBITDA	$ -787.34K	$ -748.52K	$ -3.56M	$ -9.47M	$ -128.30K	$ -329.88K

Currency in USD

Love Pharma Inc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing